Publications
2023
Prevalence of vitamin D deficiency and modifiable risk factors in patients with Crohn's disease: A prospective observational study
Fletcher, J., Brown, M., Hewison, M., Swift, A., & Cooper, S. C. (2023). Prevalence of vitamin D deficiency and modifiable risk factors in patients with Crohn's disease: A prospective observational study. JOURNAL OF ADVANCED NURSING, 79(1), 205-214. doi:10.1111/jan.15476
2021
Protocol for an open-label feasibility study for a randomised controlled trial of vitamin D supplementation in Crohn's Disease patients with vitamin D deficiency: D-CODE Feasiblity study
Fletcher, J., Bedson, E., Brown, M., Hewison, M., Swift, A., & Cooper, S. C. (2021). Protocol for an open-label feasibility study for a randomised controlled trial of vitamin D supplementation in Crohn's Disease patients with vitamin D deficiency: D-CODE Feasiblity study. PILOT AND FEASIBILITY STUDIES, 7(1). doi:10.1186/s40814-021-00813-3
Onabotulinum toxin-A versus extended release tolterodine in the management of idiopathic overactive bladder in children: A pilot randomised controlled trial (OVERT trial)
Brown, M., Williamson, P. R., Sutton, L., Melling, C., Lewis, M., J.A.Webb, N., & Goyal, A. (2021). Onabotulinum toxin-A versus extended release tolterodine in the management of idiopathic overactive bladder in children: A pilot randomised controlled trial (OVERT trial). JOURNAL OF PEDIATRIC UROLOGY, 17(1). doi:10.1016/j.jpurol.2020.10.012
Intravenous or oral antibiotic treatment in adults and children with cystic fibrosis and <i>Pseudomonas</i> <i>aeruginosa</i> infection: the TORPEDO-CF RCT
Hewer, S. C. L., Smyth, A. R., Brown, M., Jones, A. P., Hickey, H., Kenna, D., . . . Williamson, P. R. (2021). Intravenous or oral antibiotic treatment in adults and children with cystic fibrosis and <i>Pseudomonas</i> <i>aeruginosa</i> infection: the TORPEDO-CF RCT. HEALTH TECHNOLOGY ASSESSMENT, 25(65), 1-+. doi:10.3310/hta25650
2020
Antimicrobial-impregnated central venous catheters for preventing neonatal bloodstream infection: the PREVAIL RCT
Gilbert, R., Brown, M., Faria, R., Fraser, C., Donohue, C., Rainford, N., . . . Oddie, S. J. (n.d.). Antimicrobial-impregnated central venous catheters for preventing neonatal bloodstream infection: the PREVAIL RCT. Health Technology Assessment, 24(57), 1-190. doi:10.3310/hta24570
Antimicrobial-impregnated central venous catheters for preventing neonatal bloodstream infection: the PREVAIL RCT.
Gilbert, R., Brown, M., Faria, R., Fraser, C., Donohue, C., Rainford, N., . . . Oddie, S. J. (2020). Antimicrobial-impregnated central venous catheters for preventing neonatal bloodstream infection: the PREVAIL RCT.. Health technology assessment (Winchester, England), 24(57), 1-190. doi:10.1093/ije/dyw098
Intravenous versus oral antibiotics for eradication of Pseudomonas aeruginosa in cystic fibrosis (TORPEDO-CF): a randomised controlled trial
Hewer, S. C. L., Smyth, A. R., Brown, M., Jones, A. P., Hickey, H., Kenna, D., . . . Grp, T. O. R. P. E. D. O. -C. F. S. (2020). Intravenous versus oral antibiotics for eradication of Pseudomonas aeruginosa in cystic fibrosis (TORPEDO-CF): a randomised controlled trial. LANCET RESPIRATORY MEDICINE, 8(10), 975-986. doi:10.1016/S2213-2600(20)30331-3